داروسازی تولید دارو(سهامی خاص)
دتولید | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 11,890 2.94
Close Price: 11,880
Cash Flow
AGM
Interim
2026/05/19 Fiscal Year 2025/12/2112 Month / Audited | 2026/04/27 Fiscal Year 2025/12/2112 Month | ||
|---|---|---|---|
Cash Generated from Operations | -228.557 Billion | 1.604 Trillion | |
Income Taxes Paid | -63.793 Billion | -9.2 Billion | |
Net Cash Flow from Operating Activities | -292.35 Billion | 1.594 Trillion | |
Purchases of Property, Plant and Equipment | -87.525 Billion | -182.031 Billion | |
Purchases of Intangible Assets | -16.434 Billion | -16.434 Billion | |
Proceeds from Sale of Long-Term Investments | 31.717 Billion | - | |
Cash Paid to Acquire Long-Term Investments | -5 Million | -186 Million | |
Cash Received from Income on Other Investments | 305 Million | 205 Million | |
Net Cash Flow from Investing Activities | -71.942 Billion | -198.446 Billion | |
Net Cash Flow before Financing Activities | -364.292 Billion | 1.396 Trillion | |
دریافت های نقدی حاصل از افزايش سرمایه | 544.174 Billion | - | |
Proceeds from Sale of Treasury Shares | 208.928 Billion | 215.575 Billion | |
Purchases of Treasury Shares | -184.225 Billion | -190.872 Billion | |
Cash Received from Borrowings | 4.402 Trillion | 3.136 Trillion | |
Repayments of Borrowings (Principal) | -4.083 Trillion | -3.981 Trillion | |
Interest Paid on Borrowings | -585.335 Billion | -579.674 Billion | |
Dividends Paid | -16.924 Billion | -68.904 Billion | |
Net Cash Flow from Financing Activities | 285.895 Billion | -1.469 Trillion | |
Net Increase (Decrease) in Cash | -78.397 Billion | -73.112 Billion | |
Cash at Beginning of Period | 381.961 Billion | 381.961 Billion | |
Effect of Exchange Rate Changes | 5.541 Billion | 205 Million | |
Cash at End of Period | 387.502 Billion | 382.166 Billion |